| Early Phase 1 | 2 | |
| Phase 1/2 | 2 | |
| Phase 2/3 | 1 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06762548 | Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia | Chemotherapy Induced Alopecia | Not Yet Recruiting | 2025-05-23 |
| NCT06745336 | Clinical Study of CS-001 As a Treatment for Canities (Grey Hair) | Canities | Not Yet Recruiting | 2024-12-24 |
| NCT06501924 | Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss | Androgenetic Alopecia | Not Yet Recruiting | 2024-12-19 |
| Phase 2/3 | ||||
| NCT06648850 | Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth | Telogen Effluvium | Not Yet Recruiting | 2026-04-13 |
| Phase 1/2 | ||||
| NCT07397325 | Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia | Chemotherapy Induced Alopecia | Recruiting | 2026-08-21 |
| NCT07166354 | Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities) | Canities | Not Yet Recruiting | 2025-09-10 |
| Early Phase 1 | ||||
| NCT07033845 | Pharmacokinetic Study of Topical Phenylephrine | Chemotherapy Induced Alopecia | Recruiting | 2025-10-03 |
| NCT07402330 | Pharmacokinetic Study of DA-020 | Chemotherapy Induced Alopecia | Not Yet Recruiting | 2026-04-13 |